Oncology & Cancer

Burden of myeloproliferative neoplasms in Australia revealed

New research led by Cancer Council Queensland and Curtin University has investigated the patterns and trends of a rare group of blood cancers known as myeloproliferative neoplasms (MPN) for the first time in Australia.


Recommended therapies for polycythemia vera underused

(HealthDay)—Among older patients with polycythemia vera (PV), therapeutic phlebotomy and hydroxyurea (HU) are associated with improved overall survival and decreased risk for thrombosis but are underused, according to a ...

Medical research

Drug-like peptides show promise in treating two blood diseases

New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults. Although those diseases, beta-thalassemia and polycythemia vera, have opposite ...


Jakafi approved for chronic bone marrow disease

(HealthDay)—Jakafi (ruxolitinib) has been approved by the U.S. Food and Drug Administration to treat polycythemia vera, a chronic disease of the bone marrow.

Diseases, Conditions, Syndromes

Molecular method classifies patients with polycythemia vera

(HealthDay)—Patients with polycythemia vera can be classified according to disease behavior, independently of Janus kinase 2 (JAK2) V617F allele burden, after removing sex as a potential confounder, according to a study ...

page 1 from 1